{"id":3304,"count":40,"description":"Modern antiretroviral therapy (ART) has transformed HIV from a fatal diagnosis into a manageable chronic condition \u2014 with consistent treatment, life expectancy approaches normal and viral suppression makes sexual transmission essentially zero (U=U: undetectable equals untransmittable). The MedsBase HIV Medication catalogue carries the major NRTI backbones, integrase inhibitors, complete-regimen tablets, and selected adjuncts used in modern HIV treatment and PrEP. All products are supplied by WHO-GMP gecertificeerde fabrikanten<\/strong>.\n\nNRTI backbone \u2014 the foundation of ART and PrEP.<\/strong> Tenofovir disoproxil fumarate + emtricitabine (TDF\/FTC) is the most-used NRTI backbone globally \u2014 used both as part of HIV treatment regimens and as daily pre-exposure prophylaxis (PrEP). We stock Tenof EM<\/a> en Ricovir EM<\/a>. Tenofovir alafenamide + emtricitabine (TAF\/FTC) \u2014 the newer prodrug with better renal and bone safety profile \u2014 is available as Tavin EM<\/a> en Tenvir AF<\/a>. Lamivudine monotherapy (3TC, the building-block NRTI for HBV co-treatment and selected paediatric protocols) as Lamivir<\/a>. Bekijk ons PrEP Medicatie<\/a> category for the full PrEP-formatted range and our hub guide Beste PrEP Medicijnen 2026<\/a>.\n\nIntegrase strand-transfer inhibitors (INSTI).<\/strong> Modern first-line ART pairs an NRTI backbone with an integrase inhibitor (dolutegravir, bictegravir, or raltegravir) \u2014 high barrier to resistance, fewer drug interactions, and excellent tolerability. Raltegravir 400 mg is stocked as Ralmac 400<\/a> en Instgra<\/a>.\n\nComplete single-tablet regimens (STRs).<\/strong> Single-tablet once-daily regimens simplify ART and improve adherence. Avonza<\/a> combines tenofovir + lamivudine + efavirenz (TLE \u2014 the WHO first-line regimen for many years and still widely used in resource-limited settings). Teravir<\/a> provides tenofovir + lamivudine. Taficita<\/a> delivers TAF + emtricitabine + bictegravir-class integrase inhibitor, the modern preferred first-line regimen.\n\nOther NRTIs and adjuncts.<\/strong> Lamivudine + zidovudine combination (AZT\/3TC) is stocked as Hivus-LR<\/a>. Ritonavir-boosted protease inhibitor combinations as Ritocom<\/a>. Selected legacy regimens including Trioday<\/a> remain catalogued for switch \/ continuation use.\n\nHow to choose \u2014 and important caveats.<\/strong> Modern WHO and DHHS first-line guidance is dolutegravir or bictegravir + TAF\/FTC (or TDF\/FTC where TAF unavailable). Switch from older regimens (efavirenz-based, AZT-based) is appropriate for most patients but should be done in coordinated HIV-care setting. PrEP requires baseline HIV testing (negative status) and quarterly re-testing \u2014 this is essential to avoid integrase-resistance emergence in undiagnosed acute HIV. STI co-screening, hepatitis B status, renal function, and bone-density assessment are part of standard HIV \/ PrEP care.\n\nCritical.<\/strong> Do not source HIV medication without ongoing engagement with an HIV-care provider \u2014 adherence monitoring, viral load surveillance, CD4 monitoring, drug-interaction review, and resistance testing are essential for long-term safety and effectiveness. Hepatitis B co-infection requires careful regimen choice (TDF\/FTC and TAF\/FTC also treat HBV; abrupt discontinuation can cause severe HBV flare). Pregnancy: most modern regimens are safe; integrase inhibitors are increasingly preferred.\n\nAll MedsBase HIV Medication products ship from WHO-GMP gecertificeerde fabrikanten<\/strong> met discrete verpakking en vallen onder onze Reshipment Assurance Policy<\/a>.\n\n2026 buyer's guide:<\/strong> Bekijk onze selectie Best HIV Treatment Regimens 2026<\/a> voor gerangschikte keuzes, vergelijkingstabel, doseringsadviezen en beslissingshulp.","link":"https:\/\/medsbase.com\/nl\/hiv-medication\/","name":"HIV-medicatie","slug":"hiv-medication","taxonomy":"product_cat","parent":3223,"meta":[],"menu_order":0,"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product_cat\/3304","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product_cat"}],"about":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/taxonomies\/product_cat"}],"up":[{"embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product_cat\/3223"}],"wp:post_type":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product?product_cat=3304"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}